Poise Pharmysticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.32 M
- Company Age 27 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Revenue Growth 40.52%
- Profit Growth 264.37%
- Ebitda 9.83%
- Net Worth 0.79%
- Total Assets -13.52%
About Poise Pharmysticals
Poise Pharmysticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 1998 and has a history of 27 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.32 M.
The company currently has active open charges totaling ₹0.50 M.
Arun Arora and Jawahar Singh serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U34232DL1998PTC091500
- Company No.
091500
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1998
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Poise Pharmysticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Arora  | Director | 20-Feb-1998 | Current |
| Jawahar Singh | Director | 05-Jan-1998 | Current |
Financial Performance of Poise Pharmysticals.
Poise Pharmysticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.52% increase. The company also saw a substantial improvement in profitability, with a 264.37% increase in profit. The company's net worth moved up by a moderate rise of 0.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Poise Pharmysticals?
In 2022, Poise Pharmysticals had a promoter holding of 71.21% and a public holding of 28.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Central Bank Of India : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2003 | Central Bank Of India | ₹0.50 M | Open |
How Many Employees Work at Poise Pharmysticals?
Unlock and access historical data on people associated with Poise Pharmysticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Poise Pharmysticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Poise Pharmysticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.